About BDS: Empowering Laboratories, Improving Lives
From the start, we have been driven by a passion for innovation and a commitment to customer success. It’s in our DNA to empower laboratories and improve patient care.

Our vision
To be the leading provider of high-quality laboratory software, empowering professionals in improving patient care, supporting compliance, and managing sustainability.
We believe in:
The BDS team: highly experienced lab and development professionals, with decades of specialised industry experience
Guided by a commitment to excellence, our seasoned development team is at the heart of our mission—fuelled by a passion for the impactful software we create, and the market sectors we serve. This dedication propels our technological innovations and empowers end-users to provide unparallelled patient care through our safety-critical software solutions.
Our Leadership Team




Rebecca Stead
Managing Director
Rebecca leads the team at BDS in delivering quality software products while managing the organisation’s long-term strategy. Rebecca has over 17 years’ experience in the medical device software industry, starting her career as a software developer and advancing to Project Manager, SVP of Operations and Development and, since May 2020, Managing Director. Rebecca holds a BSc in Business Information Systems from the University of Liverpool, and an MBA from the Open University.
Shaun Northedge
CEO & Managing Director
Ian Williams
CPO
Chief Product Officer at Biomedical Data Solutions, leading Product, Regulatory, and Commercial strategy for healthcare IT: LIMS, Middleware, Instrument connectivity, and lab compliance software, backed by 35+ years’ Biomedical Science and NHS experience. I work alongside the rest of the C-Suite to shape our product portfolio and long-term growth.
I started out as a qualified Biomedical Scientist, working in Blood Sciences and Transfusion before moving into healthcare IT. Over 35+ years I’ve worked across the NHS, hospital, and laboratory environments; LIMS, order communications, electronic reporting, e-discharge, clinical whiteboards, clinical documentation, blood tracking, and lab-to-lab referral systems. That background means I can talk credibly with clinicians, lab staff, technical teams, and partners, because I’ve done the job they’re describing.
Joining the Senior Leadership Team three years ago, I moved from hands-on delivery to owning our product direction, regulatory compliance, and commercial performance. In practice, that means staying close to end users to understand what’s needed on the ground, while working with partners on how our software gets to market.
At BDS, we partner with businesses to build healthcare IT solutions that meet both their needs and those of their end users. We work across a range of approaches, from fully tailored development on our Enterprise platform, to off-the-shelf tools, particularly on the middleware and communications side. Most are white-labelled, running under our partners’ brand while we handle the build and support, though occasionally under ours. We’re also increasingly building AI-enabled capability into our lab and diagnostics products. Alongside this, our Vigilant platform (VLS) helps labs maintain ISO compliance, covering asset management, stock tracking, task maintenance, and training and competency management.
On top of the solutions themselves, we offer Business Analysis, Regulatory, Cyber Security, and Implementation services. We work closely with many of the leading diagnostic instrument suppliers, including Roche, Werfen, Grifols, Hamilton, Bio-Rad, and Hologic, giving us a detailed understanding of how our software needs to operate across a wide range of instrument and laboratory environments.
I’m always keen to talk to labs, trusts, and partners working through connectivity, compliance, or instrument integration challenges, whether that’s a new build, an off-the-shelf fit, or something in between. If that’s you, get in touch.
Oliver Clarke
CTO
- Setting technical direction that supports business goals, from product roadmap to build-versus-buy and AI adoption decisions
- Building and leading multidisciplinary teams of up to 50 across software development, testing, IT and cyber security, onshore and offshore, in regulated environments
- Turning regulatory and security requirements into a competitive advantage customers can trust, with hands-on experience of ISO 27001, ISO 13485 and IEC 62304
- Representing our technology to customers, partners and stakeholders, and translating complex science and engineering into clear decisions
Founded in 1983, BDS has a rich history of innovation and growth. We have evolved from a UK-based company focused on donor screening and transfusion medicine to a global leader in laboratory software solutions.
Quality and Regulatory Compliance: It's in our DNA
At BDS, we understand that regulatory compliance is critical for our customers. It’s not just about meeting requirements; it’s about ensuring patient safety and maintaining the highest standards of quality. That’s why we’ve built a culture of compliance into everything we do. It’s in our DNA.
At BDS, we understand that regulatory compliance is critical for our customers. It’s not just about meeting requirements; it’s about ensuring patient safety and maintaining the highest standards of quality. That’s why we’ve built a culture of compliance into everything we do. It’s in our DNA.
Our Quality Management System is ISO 13485/MDSAP-certified, and we are committed to staying ahead of the curve, constantly monitoring and adapting to evolving regulations to ensure our solutions meet the latest standards. We also prioritise cybersecurity, implementing robust measures to protect sensitive data and maintain the integrity of our systems.


We believe that compliance is not just a box to check; it’s an integral part of delivering high-quality solutions that our customers can trust. It’s in our DNA to support your compliance efforts, giving you the confidence to focus on what matters most: improving patient care.
BDS & TSS
BDS is proud to be a vital part of Total Specific Solutions (TSS) within the broader Constellation Software Inc. (CSI) ecosystem. Our unique position as an autonomous business unit within TSS allows us to deeply understand and effectively serve our customers and market with specialised solutions. The autonomous approach taken by TSS means that BDS can focus their passion, experience and expertise on our customers in our ultimate goal, to improve patient care through laboratory and diagnostic testing and blood safety whilst having access to the vast knowledge and experience across thousands of other software businesses.